市场调查报告书
商品编码
1503420
到 2030 年质谱软体市场预测:按类型、部署类型、技术、应用、最终用户和地区进行的全球分析Mass Spectrometry Software Market Forecasts to 2030 - Global Analysis By Type, Deployment Type, Technology, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球质谱软体市场规模将达到 63 亿美元,预计到 2030 年将达到 126 亿美元,预测期内复合年增长率为 10.3%。
质谱软体是指设计用于分析质谱仪产生的资料的电脑程式。这些工具透过根据质荷比识别和量化分子来帮助解释复杂的频谱。它们通常包括资料处理、峰值检测、分子结构阐明和统计分析等功能,这些功能对于蛋白质组学、代谢体学和环境分析等应用至关重要。此类软体有助于从原始质谱资料中高效、准确地提取有意义的信息,在现代科学研究中发挥重要作用。
据製造商称,最新的质谱仪比其前身小 45%,并且使用的天然气和电力减少了 50%。
个人化医疗需求不断成长
对个人化医疗解决方案的需求正在迅速增长。技术的进步使得软体能够更准确地分析个别患者的资料,从而更容易制定量身定制的治疗计划。这一趋势反映了向精准医疗的转变,精准医疗在根据患者俱体特征优化药物疗效和最大限度减少副作用方面发挥关键作用。随着医疗保健产业接受个人化医疗,市场预计将大幅成长,以满足这些不断变化的需求。
缺乏熟练的专业人员
市场面临一个重大挑战:缺乏能够有效利用先进分析工具并解释复杂资料输出的熟练专业人员。这种不足阻碍了产业创新和优化软体解决方案以满足不断变化的科学需求的能力。随着对准确性和可靠性的要求不断提高,弥合这一技能差距对于释放质谱技术在研究、製药和环境分析领域的全部潜力至关重要。
质谱技术的进步
质谱软体的最新进展透过提高灵敏度、分辨率和分析速度彻底改变了市场。创新技术包括即时资料处理、复杂资料解释的改进演算法以及与人工智慧的整合以进行预测分析。这些发展使得我们能够更深入地了解分子结构、更快地识别化合物以及在製药、环境分析和蛋白质组学等各种应用中更准确地进行定量。
资料复杂度
质谱分析会产生大量结构复杂、高维度的资料,需要复杂的软体解决方案来进行准确的分析和解释。挑战包括处理不同的资料格式、与不同的仪器平台整合以及确保资料处理和可视化的强大演算法。解决这些复杂性对于增强资料驱动的洞察力、提高分子鑑定的准确性以及推进蛋白质组学、代谢体学和临床诊断等领域的应用至关重要。
COVID-19 大流行对市场产生了重大影响,实验室面临业务中断和研究计划延迟的问题。儘管最初遇到了挫折,但市场适应了对远端功能和资料分析工具日益增长的需求。基于云端基础的解决方案和虚拟协作的创新已经出现,以推动復苏和成长。这些公司正在转向提高效率和扩充性的软体解决方案,这反映出该行业在全球健康挑战中的技术整合和远端工作能力方法中出现的弹性。
脂类组学领域预计将成为预测期内最大的市场。
脂类组学预计将是预测期内规模最大的。软体解决方案对于资料处理、脂质识别和质谱资料定量至关重要。该市场的主要参与者专注于开发用户友好的介面、开发用于脂类组学资料解释的强大演算法以及与现有分析工作流程整合。随着脂类组学在生物医学研究和临床诊断中的地位日益突出,解决脂质分析复杂性的技术创新预计将进一步扩大市场。
食品和饮料产业预计在预测期内复合年增长率最高
食品和饮料行业预计在预测期内复合年增长率最高。这些工具对于确保食品安全、品管和遵守监管标准至关重要。能够准确分析污染物、添加剂和营养成分,进而提高产品完整性和消费者信心。随着公司优先考虑流程的效率和准确性,市场持续成长。
在分析技术进步以及製药、生物技术和环境科学研究不断增加的推动下,预计北美在预测期内将占据最大的市场占有率。主要企业主导市场,提供复杂的软体解决方案,提高分析能力和资料处理效率。该地区对研发的大力投资以及对精准医疗和个人化医疗保健的关注正在推动对先进质谱软体解决方案的需求,并进一步推动市场扩张。
预计亚太地区在预测期内将维持最高的复合年增长率。由于医疗成本上升、慢性病盛行率增加以及人口老化,医疗保健产业正在迅速扩张。质谱广泛应用于临床诊断、生物标记发现和药物开发,形成相关软体解决方案的重要市场。该地区各国政府支持旨在提高科学研究能力和促进创新的倡议。
According to Stratistics MRC, the Global Mass Spectrometry Software Market is accounted for $6.3 billion in 2024 and is expected to reach $12.6 billion by 2030 growing at a CAGR of 10.3% during the forecast period. Mass spectrometry software refers to computer programs designed to analyze data generated by mass spectrometry instruments. These tools aid in the interpretation of complex spectra by identifying and quantifying molecules based on their mass-to-charge ratios. They often include features for data processing, peak detection, molecular structure elucidation, and statistical analysis, crucial for applications in proteomics, metabolomics, and environmental analysis. Such software plays a vital role in modern scientific research, facilitating the extraction of meaningful information from raw mass spectrometry data efficiently and accurately.
According to the manufacturer, its most recent mass spectrometer is 45% smaller and uses up to 50% less gas and electricity than its predecessor while being up to 15X more sensitive for assessing negatively ionizing chemicals.
Growing demand for personalized medicine
The market is experiencing a surge in demand for personalized medicine solutions. Advances in technology have enabled software to analyze individual patient data more accurately, facilitating tailored treatment plans. This trend reflects a shift towards precision healthcare, where it plays a crucial role in optimizing drug effectiveness and minimizing side effects based on patient-specific characteristics. As the healthcare industry embraces personalized medicine, the market is expected to grow significantly to meet these evolving needs.
Lack of skilled professionals
The market faces a significant challenge due to a shortage of skilled professionals capable of effectively utilizing advanced analytical tools and interpreting complex data outputs. This shortage hinders the industry's ability to innovate and optimize software solutions tailored to evolving scientific needs. As demand for precision and reliability grows, bridging this skills gap becomes crucial for maximizing the potential of mass spectrometry technologies in research, pharmaceuticals, and environmental analysis sectors.
Technological advancements in mass spectrometry
Recent advancements in mass spectrometry software have revolutionized the market by enhancing sensitivity, resolution, and speed of analysis. Innovations include real-time data processing, improved algorithms for complex data interpretation, and integration with artificial intelligence for predictive analytics. These developments enable deeper insights into molecular structures, faster identification of compounds, and more precise quantification in various applications such as pharmaceuticals, environmental analysis, and proteomics.
Data complexity
Mass spectrometry generates vast amounts of data with intricate structures and high dimensionality, requiring sophisticated software solutions for accurate analysis and interpretation. Challenges include handling diverse data formats, integrating with various instrumentation platforms, and ensuring robust algorithms for data processing and visualization. Addressing these complexities is crucial for enhancing data-driven insights, improving accuracy in molecular identification, and advancing applications in fields like proteomics, metabolomics, and clinical diagnostics.
The COVID-19 pandemic significantly impacted the market as laboratories faced operational disruptions and delays in research projects. Despite initial setbacks, the market adapted with increased demand for remote capabilities and data analysis tools. Innovations in cloud-based solutions and virtual collaborations emerged, driving recovery and growth. Companies pivoted towards software solutions enhancing efficiency and scalability, reflecting a resilient shift in the industry's approach to technological integration and remote work capabilities amidst global health challenges.
The lipidomics segment is expected to be the largest during the forecast period
The lipidomics is expected to be the largest during the forecast period. Software solutions are crucial for data processing, lipid identification, and quantification from mass spectrometry data. Key players in this market focus on developing user-friendly interfaces, robust algorithms for lipidomic data interpretation, and integration with existing analytical workflows. As lipidomics gains prominence in biomedical research and clinical diagnostics, the market is expected to expand further with innovations addressing the complexities of lipid analysis.
The food and beverage industry segment is expected to have the highest CAGR during the forecast period
The food and beverage industry segment is expected to have the highest CAGR during the forecast period. These tools are integral for ensuring food safety, quality control, and compliance with regulatory standards. They enable precise analysis of contaminants, additives, and nutritional components, thereby enhancing product integrity and consumer confidence. The market sees continuous growth as companies prioritize efficiency and accuracy in their processes.
North America is projected to hold the largest market share during the forecast period driven by advancements in analytical techniques and increasing research in pharmaceuticals, biotechnology, and environmental sciences. Key players dominate the market, offering sophisticated software solutions that enhance analytical capabilities and data processing efficiency. The region's strong investment in research and development further fuels market expansion, with a focus on precision medicine and personalized healthcare driving demand for advanced mass spectrometry software solutions.
Asia Pacific is projected to hold the highest CAGR over the forecast period. The healthcare industry is expanding rapidly due to rising healthcare expenditure, increasing chronic diseases, and a growing aging population. Mass spectrometry is widely used in clinical diagnostics, biomarker discovery, and drug development, creating a significant market for related software solutions. Governments across the region are supporting initiatives aimed at enhancing scientific research capabilities and fostering innovation.
Key players in the market
Some of the key players in Mass Spectrometry Software market include Thermo Fisher Scientific, Waters Corporation, Agilent Technologies, Bruker Corporation, Shimadzu Corporation, PerkinElmer, JEOL Ltd, Bio-Rad Laboratories, LECO Corporation, Advion, Peak Scientific Instruments, Rigaku Corporation, AMETEK Process Instruments, Hitachi High-Technologies Corporation, Pfeiffer Vacuum, Oxford Instruments and Teledyne CETAC Technologies.
In June 2023, Agilent Technologies Inc. announced two new liquid chromatography mass spectrometry systems (LCMS), the Agilent 6495D LC/TQ and the Agilent Revident LC/Q-TOF. Facilitating the high-end performance of the Revident LC/Q-TOF, Agilent is also announcing the new Agilent MassHunter Explorer Profiling software and the new Agilent ChemVista library manager software.
In August 2023, Thermo Fisher Scientific has announced the commercial launch of the EXENT Solution, after receiving IVDR certification. The EXENT solution is a fully integrated and automated mass spectrometry system designed to transform diagnosis and assessment for patients with monoclonal gammopathies, including multiple myeloma which, according to the World Health Organisation in 2020, is the second most prevalent blood cancer worldwide.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.